$IUGNF/$IMU(ASX)CANCER treatment/not ur avg penny play
We have received ethics approval from the external independent Human Research Ethics Committee (HREC) in Australia and Independent Review Boards (IRB'S) in the USA, in addition to the coveted US FDA Investigational New Drug (IND) approval to begin Phase 1 clinical trails of our immunotherapy drug, PD1-Vaxx. Read the entire newsletter with links on site.
From the Chairman Paul Hopper in Dec newsletter: "I believe you are about to see the faith you've placed in us be acknowledged in a positive fashion."